Description
Recigar is a medicinal product that helps reduce nicotine cravings and supports smoking cessation. It is intended for use in adults.
Ingredients
The active substance in Recigar is cytisine. Each tablet contains 1.5 mg of cytisine.
Other ingredients:
Tablet core: hypromellose, mannitol, corn starch, magnesium aluminium silicate, colloidal anhydrous silica, magnesium stearate.
Coating: AquaPolish P green Project [hypromellose (E464), microcrystalline cellulose (E460), talc (E553b), glycerol, titanium dioxide (E171), quinoline yellow lake (E104), indigotine lake (Blue No. 2) (E132)], menthol flavouring powder (SC552873), aspartame (E951).
Dosage
One pack of Recigar tablets (100 tablets) is sufficient for a full course of therapy. The treatment lasts 25 days. The tablets should be taken orally with an adequate amount of water according to the following schedule:
| Day | Dosage |
|---|---|
| 1–3 | 1 tablet every 2 hours (maximum 6 tablets per day) |
| 4–12 | 1 tablet every 2.5 hours (maximum 5 tablets per day) |
| 13–16 | 1 tablet every 3 hours (maximum 4 tablets per day) |
| 17–20 | 1 tablet every 5 hours (maximum 3 tablets per day) |
| 21–25 | 1–2 tablets daily (maximum 2 tablets per day) |
Mechanism of Action
Recigar contains cytisine, an alkaloid that acts on nicotinic receptors. Cytisine competes with nicotine for the same receptors, binding more strongly and gradually displacing nicotine. This process helps reduce nicotine dependence and supports effective smoking cessation without severe withdrawal symptoms.
Indications
Recigar is indicated for the cessation of tobacco use and for reducing nicotine cravings in individuals who wish to stop smoking. The ultimate goal of therapy is permanent discontinuation of nicotine-containing products.
Contraindications
Recigar should not be used:
-
in patients allergic to cytisine or any of the excipients,
-
in cases of unstable angina,
-
after a recent myocardial infarction,
-
in clinically significant cardiac arrhythmias,
-
after a recent stroke,
-
during pregnancy or breastfeeding.
Adverse Reactions
Like all medicines, this product may cause side effects, although not everyone will experience them. Potential adverse reactions are described in the Recigar package leaflet.
Warnings and Precautions
Before starting Recigar, consult a doctor or pharmacist if the patient has:
ischemic heart disease, heart failure, hypertension, pheochromocytoma, atherosclerosis or peripheral vascular disease, gastric or duodenal ulcer disease, gastroesophageal reflux disease, hyperthyroidism, diabetes, schizophrenia, renal or hepatic impairment, or if the patient is over 65 years of age.
Recigar should only be used by individuals with a strong intention to stop smoking.
Taking the medicine while continuing to smoke may increase nicotine-related adverse effects.
Use with Other Medicines
Recigar should not be taken together with anti-tuberculosis drugs.
In some cases, smoking cessation—whether with or without Recigar—may require dose adjustments of other medications. This is particularly important for medicines containing theophylline (for asthma), tacrine (for Alzheimer’s disease), clozapine (for schizophrenia), and ropinirole (for Parkinson’s disease).
Consult a doctor or pharmacist if unsure.
Pregnancy and Breastfeeding
Recigar is contraindicated during breastfeeding.
Women of childbearing potential must use effective contraception during treatment.
Consult a healthcare professional for further advice.
Use in Children and Adolescents
Due to limited clinical experience, Recigar is not recommended for children and adolescents under 18 years of age.
Effects on Ability to Drive and Use Machines
Recigar has no or negligible influence on the ability to drive or operate machinery.
